New Rhein Healthcare Investors, LLC

What is New Rhein Healthcare Investors, LLC?

New Rhein Healthcare Investors, LLC is a private equity firm specializing in investments in the healthcare sector, with a particular emphasis on life sciences and pharmaceuticals. The firm applies a private equity business model to life sciences venture capital investing, aiming to invest in assets with proven clinical safety and efficacy that can be applied in new ways, such as through new delivery forms or new indications.

Their goal is to develop products that offer significant health benefits to patients and provide compelling economic value to payors. With an emphasis on equity and specialties in expansion and later stages, New Rhein is known for limiting science-based risk and focusing on the successful development and execution of product development and commercialization.

The company is based in Philadelphia, Pennsylvania, and has an expertise in managing significant stakes in a small number of companies while actively managing their value creation. New Rhein's investment strategy emphasizes taking a hands-on approach in managing and scaling portfolio companies with the objective of driving successful exits that benefit patients, payors, strategic acquirers, and investors.

The fund's assets under management amount to $47 million. New Rhein's team boasts more than 65 years of combined industry experience, specializing in R&D, commercialization, and M&A.

This expertise underpins their ability to source deals, perform due diligence, and make informed management decisions. Their previous investments include products for diseases like Alzheimer's, ocular disorders, respiratory diseases, critical care, urology, and oncology.

The New Rhein Funds II and III have invested in companies focusing on treatments for conditions such as COPD, BPH, COVID-19, and migraines, among others. The firm also provides operational experience, relationship networks, and business acumen to help portfolio companies grow.